General Enquiries
+44 (0)20 7234 2009

Haemato-oncology Update

    Thursday 22nd February 2018
    18:30 to 20:45
    Glaziers Hall 9 Montague Close London Bridge London, SE1 9DD
    Join Dr Majid Kazmi Consultant Haematologist and Dr Donal McLornan Consultant in Haematology and Stem Cell Transplantation for a Haemato - oncology Update covering the topics of MGUS is it really benign? Stem Cell Transplant for MS what you need to know and what’s new in Leukaemia/ MDS/MPN.
    Dr Majid Kazmi Dr Donal McLornan
    TimeSessionSpeaker
    6.30pm - 7.00pm Arrival & Registration
    7.00pm - 7.35pm Dr Donal McLornan Haemato-oncology – what’s new in Leukaemia/ MDS/MPN
    7.35pm - 8.10pm Dr Majid Kazmi MGUS is it really benign? Stem Cell Transplant for MS what you need to know
    8.10pm - 8.45pm Q&A

    Dr Majid Kazmi is a consultant Haematologist. Dr Kazmi qualified from the University of Aberdeen in 1991 with Commendation, he is a member of European group for Blood and Marrow Transplantation (EBMT) and American Society of Haematology (ASH). He has been a consultant in Haemato-oncology since 2001 at Guy’s & ST Thomas’ NHS Foundation Trust and King’s College Hospital NHS Foundation Trust. His private work is at LOC (London Bridge Hospital). His special interests include Bone marrow transplantation, myeloma, lymphoma, leukaemia and general haematology, stem cell transplantation for auto-immune diseases.

    Dr Donal McLornan graduated in 1999 from Queen’s University belfast with Honours. Postgraduate training was completed in Belfast with a further one year period spent in Hammersmith Hospital specialising in Allogeneic and Autologous Stem Cell Transplantation. During his post-graduate training he was awarded a prestigious MRC fellowship and completed a PhD investigating drug resistance in Acute Myeloid Leukaemia for which he received several awards. Clinically he specialises in Haemato-oncology and Stem Cell Transplantation. He has a particular interest in Myeloproliferative Disorders, Myelodysplasia, Acute Myeloid Leukaemia and Allogeneic Stem Cell Transplantation. He sits on the NCRN MPN working group and the Chronic Malignancy Working Party of EBMT and is the lead for the Myeloid Disorders MDM across South East London. He has authored over 50 papers and has a special reserach interest in Myeloproliferative Disease. He is a member of EHA, EBMT and BSH. He regularly speaks internationally on MPN, MDS and allogeneic SCT.